首页> 美国卫生研究院文献>Chronic Diseases and Translational Medicine >Current advances in circulating inflammatory biomarkers in atherosclerosis and related cardio-cerebrovascular diseases
【2h】

Current advances in circulating inflammatory biomarkers in atherosclerosis and related cardio-cerebrovascular diseases

机译:动脉粥样硬化和相关心脑血管疾病中循环炎症生物标志物的最新进展

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Atherosclerosis (AS) is a systemic chronic disease affecting both the coronary and cerebral arteries. Inflammation plays a key role in the initiation and progression of AS, and numerous inflammatory factors have been proposed as potential biomarkers. This article reviews recent research in studies on major circulating inflammatory biomarkers to identify surrogates that may reflect processes associated with AS development and the risk of AS-related vascular events, such as Von Willebrand factor, lectin-like oxidized low-density-lipoprotein receptor-1, soluble urokinase plasminogen activator receptor, regulated upon activation, normal T-cell expressed and secreted, and microparticles, which may provide new perspectives for clinical AS evaluation and risk stratification.
机译:动脉粥样硬化(AS)是一种影响冠状动脉和脑动脉的全身性慢性疾病。炎症在AS的发生和发展中起着关键作用,许多炎症因子被认为是潜在的生物标志物。本文回顾了最近在主要循环炎症生物标志物研究中的研究,以确定可能反映与AS发育相关的过程以及与AS相关的血管事件的风险的替代物,例如Von Willebrand因子,凝集素样氧化型低密度脂蛋白受体- 1,可溶性尿激酶纤溶酶原激活剂受体,在激活,正常T细胞的表达和分泌以及微粒方面受到调节,这可能为临床AS评估和风险分层提供新的观点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号